PRKN and amyotrophic lateral sclerosis: Arguably, some may consider Parkin’s role in these diseases as a passenger, i.e., a consequence of AD or ALS-related pathogenic factors going awry, although several reports demonstrated that Parkin overexpression is beneficial in these cases.